JUSTIN XU: Open Payments
NPI 1285479667 · ALHAMBRA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,086 in 34 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $346 · 2025 $1,086
Food & beverage: $1,006Education: $80
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $225 |
| Agios Pharmaceuticals, Inc. | 1 | $140 |
| Merck Sharp & Dohme LLC | 6 | $137 |
| Novo Nordisk Inc | 4 | $93 |
| PFIZER INC. | 4 | $90 |
| SEAGEN INC. | 1 | $80 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $63 |
| Lilly USA, LLC | 2 | $41 |
| GlaxoSmithKline, LLC. | 1 | $32 |
| Aveo Pharmaceuticals, Inc. | 1 | $29 |
Products named: OTEZLA, PYRUKYND, KEYTRUDA, Ozempic, PREVNAR 20, XTANDI, MOUNJARO, FRUZAQLA.
Industry payments across CA — which companies pay providers there.
